| GTO ID | GTC3892 |
| Trial ID | NCT06430736 |
| Disease | Myeloma | Lymphoma | Leukemia |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Co-treatment | Tocilizumab |
| Phase | Phase2 |
| Recruitment status | Recruiting |
| Title | Prospective Comparison Between Prophylactic and On-demand Use of Tocilizumab in CAR-T Recipients - a Randomized, Two Arm, Open-label, Single-center Trial |
| Year | 2024 |
| Country | Switzerland |
| Company sponsor | Insel Gruppe AG, University Hospital Bern |
| Other ID(s) | PRONTO |
| Cohort 1 | |||||||
|
|||||||